These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20596678)

  • 1. Prognostic significance of second mitochondria-derived activator of caspase (Smac/DIABLO) expression in bladder cancer and target for therapy.
    Mizutani Y; Katsuoka Y; Bonavida B
    Int J Oncol; 2010 Aug; 37(2):503-8. PubMed ID: 20596678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low circulating serum levels of second mitochondria-derived activator of caspase (Smac/DIABLO) in patients with bladder cancer.
    Mizutani Y; Katsuoka Y; Bonavida B
    Int J Oncol; 2012 Apr; 40(4):1246-50. PubMed ID: 22218530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significance.
    Mizutani Y; Nakanishi H; Yamamoto K; Li YN; Matsubara H; Mikami K; Okihara K; Kawauchi A; Bonavida B; Miki T
    J Clin Oncol; 2005 Jan; 23(3):448-54. PubMed ID: 15572731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of smac/DIABLO in endometrioid endometrial cancer.
    Dobrzycka B; Terlikowski SJ; Bernaczyk PS; Garbowicz M; Niklinski J; Chyczewski L; Kulikowski M
    Folia Histochem Cytobiol; 2010 Dec; 48(4):678-81. PubMed ID: 21478115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smac/DIABLO enhances the therapeutic potential of chemotherapeutic drugs and irradiation, and sensitizes TRAIL-resistant breast cancer cells.
    Fandy TE; Shankar S; Srivastava RK
    Mol Cancer; 2008 Jun; 7():60. PubMed ID: 18590557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression levels of the mitochondrial IAP antagonists Smac/DIABLO and Omi/HtrA2 in clear-cell renal cell carcinomas and their prognostic value.
    Kempkensteffen C; Hinz S; Christoph F; Krause H; Magheli A; Schrader M; Schostak M; Miller K; Weikert S
    J Cancer Res Clin Oncol; 2008 May; 134(5):543-50. PubMed ID: 17922292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfection of Smac/DIABLO sensitizes drug-resistant tumor cells to TRAIL or paclitaxel-induced apoptosis in vitro.
    Mao HL; Liu PS; Zheng JF; Zhang PH; Zhou LG; Xin G; Liu C
    Pharmacol Res; 2007 Dec; 56(6):483-92. PubMed ID: 18029193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of Smac/DIABLO protein expression with the clinico-pathological features of breast cancer patients.
    Pluta P; Cebula-Obrzut B; Ehemann V; Pluta A; Wierzbowska A; Piekarski J; Bilski A; Nejc D; Kordek R; Robak T; Smolewski P; Jeziorski A
    Neoplasma; 2011; 58(5):430-5. PubMed ID: 21744997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of Smac/DIABLO expression in colorectal cancer.
    Endo K; Kohnoe S; Watanabe A; Tashiro H; Sakata H; Morita M; Kakeji Y; Maehara Y
    Oncol Rep; 2009 Feb; 21(2):351-5. PubMed ID: 19148507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD56 and CD11b Positivity with Low Smac/DIABLO Expression as Predictors of Chemoresistance in Acute Myeloid Leukaemia: Flow Cytometric Analysis.
    Ibrahim A; Zahran AM; Aly SS; Refaat A; Hassan MH
    Asian Pac J Cancer Prev; 2018 Nov; 19(11):3187-3192. PubMed ID: 30486609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of pretreatment VEGF, survivin, and Smac/DIABLO serum levels in patients with serous ovarian carcinoma.
    Dobrzycka B; Mackowiak-Matejczyk B; Terlikowska KM; Kulesza-Bronczyk B; Kinalski M; Terlikowski SJ
    Tumour Biol; 2015 Jun; 36(6):4157-65. PubMed ID: 25577253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired kinetics of Bax-GFP and Smac/DIABLO-GFP in caspase-8- and bid-silenced and Bcl-2 overexpressed breast cancer MCF-7 cells exposed to camptothecin.
    Górka M; Lamparska-Przybysz M; Motyl T
    Cell Mol Biol (Noisy-le-grand); 2007 Jan; 52 Suppl():OL915-22. PubMed ID: 17666167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smac/DIABLO promotes mitomycin C-induced apoptosis of bladder cancer T24 cells.
    Wang L; Fuqing Z; Zheng L; Tong Q
    J Huazhong Univ Sci Technolog Med Sci; 2006; 26(3):317-8, 328. PubMed ID: 16961280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical analysis of Smac/DIABLO expression in human carcinomas and sarcomas.
    Yoo NJ; Kim HS; Kim SY; Park WS; Park CH; Jeon H; Jung ES; Lee JY; Lee SH
    APMIS; 2003 Mar; 111(3):382-8. PubMed ID: 12752217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-27a regulates the sensitivity of breast cancer cells to cisplatin treatment via BAK-SMAC/DIABLO-XIAP axis.
    Zhou S; Huang Q; Zheng S; Lin K; You J; Zhang X
    Tumour Biol; 2016 May; 37(5):6837-45. PubMed ID: 26662313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smac/DIABLO regulates the apoptosis of hypertrophic scar fibroblasts.
    Liu BH; Chen L; Li SR; Wang ZX; Cheng WG
    Int J Mol Med; 2013 Sep; 32(3):615-22. PubMed ID: 23857156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Smac/DIABLO is a novel prognostic marker in lung cancer.
    Sekimura A; Konishi A; Mizuno K; Kobayashi Y; Sasaki H; Yano M; Fukai I; Fujii Y
    Oncol Rep; 2004 Apr; 11(4):797-802. PubMed ID: 15010875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between expression of Smac and Survivin and apoptosis of primary hepatocellular carcinoma.
    Bao ST; Gui SQ; Lin MS
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):580-3. PubMed ID: 17085346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbonic anhydrase IX in bladder cancer: a diagnostic, prognostic, and therapeutic molecular marker.
    Klatte T; Seligson DB; Rao JY; Yu H; de Martino M; Kawaoka K; Wong SG; Belldegrun AS; Pantuck AJ
    Cancer; 2009 Apr; 115(7):1448-58. PubMed ID: 19195047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CLIC4, ERp29, and Smac/DIABLO derived from metastatic cancer stem-like cells stratify prognostic risks of colorectal cancer.
    Deng YJ; Tang N; Liu C; Zhang JY; An SL; Peng YL; Ma LL; Li GQ; Jiang Q; Hu CT; Wang YN; Liang YZ; Bian XW; Fang WG; Ding YQ
    Clin Cancer Res; 2014 Jul; 20(14):3809-17. PubMed ID: 24916695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.